Investment Rationale
Molecular diagnostics is a large growing market
No clear leader established
Ideal platform to revolutionize molecular diagnostics
Aggressive test introduction schedule for 2002
Comprehensive intellectual property position
- Forty-eight (48) issued U.S., thirty-seven (37) foreign patents
Strong management team – experienced in diagnostics
- 150+ years of combined diagnostic field experience
- Customer-centric focus